EGFR and central nervous system cancer: Due to epidermal growth factor receptor (EGFR) amplification, PTEN depletion and possible other mutations, overactivation of PI3K-Akt-mammalian target of rapamycin (mTOR) cascade is commonly detected in human glioma [5, 6].